Leonard Nimoy: Lived Long and Prospered
Leonard Nimoy, most famous for his iconic portrayal of Spock on the Star Trek TV series, died Friday at his Los Angeles home at the age of 83.
How a Healthy Diet Could Benefit Your Lungs
As if boosting heart health and cutting cancer risk weren't good enough reasons to eat a healthy diet, new evidence suggests that chowing down on healthy fare may also help keep your lungs healthy.
Spiriva Respimat Inhalation Spray Now Available in the United States
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray is now available by prescription through retail pharmacies across the United States.
City Address Not the Culprit in Kids' Asthma Risk
Worried about the effect of that smoggy city air on your child? You may be able to breathe easy. Part of the asthma rate in cities may be tied to factors other than the air.
Sleep on It: Asthma Tied to Sleep Breathing Problems
It's a twist on the classic puzzle about the chicken and the egg. Which comes first — asthma or sleep apnea?
Asthma Inhalers, Allergy Devices Could Save Lives
In a severe allergy attack, patients may need to take medication fast — and using medication incorrectly could slow this process. Many patients may need more education on how to use their medications properly.
Immune Diseases Were More Common in Those Born by C-Section
Could the birth process have a role in immune disease development? A common birthing method may raise babies' risk of immune diseases later, a new study found.
Asthma May Put the Heart in Peril
Asthma and heart attack may share similar symptoms, such as chest tightness and shortness of breath. The link between the two, however, may go beyond that. Asthma may increase the odds of having a heart attack.
Sleep Apnea Procedure May Improve Childhood Asthma
Asthma attacks can be stressful health scares for both children and their parents. But new research shows that a sleep disorder treatment could offer relief.
FDA Approves Two Medications for Idiopathic Pulmonary Fibrosis
Until Wednesday, people with idiopathic pulmonary fibrosis (IPF) had limited treatment options. Treatment options for this chronic lung condition expanded when the US Food and Drug Administration (FDA) approved two separate medications to treat IPF.